NEU 0.00% $19.97 neuren pharmaceuticals limited

Ann: P2 trial shows significant improvements in Phelan-McDermid, page-179

  1. 1,157 Posts.
    lightbulb Created with Sketch. 291
    i wonder how long it would take them to upgrade it further based on the share price performance this time around. Funny they downgraded it to 'hold' on the eve of the phase 2 result. what a complete joke..
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.